Blonder Tongue Laboratories (BDRLQ) Stock Statistics & Valuation Metrics

Blonder Tongue Laboratories has a market cap or net worth of $2.90K. The enterprise value is $8.09M.

Blonder Tongue Laboratories has 14,523,073 shares outstanding. The number of shares has decreased by -2.65% in one year.

Blonder Tongue Laboratories’s return on equity (ROE) is 0.72 and return on invested capital (ROIC) is -10.64%.

The current PE Ratio of Blonder Tongue Laboratories is ―. Blonder Tongue Laboratories’s PEG ratio is 0.03.

In the last 12 months, Blonder Tongue Laboratories had revenue of 11.16M and earned -1.25M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was 1.09M and capital expenditures -89.00K, giving a free cash flow of 1.00M billion.

Blonder Tongue Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Blonder Tongue Laboratories upcoming earnings date is Nov 15, 2023, Before Open (Confirmed).

Blonder Tongue Laboratories as a current ratio of 0.60, with Debt / Equity ratio of -470.73%

In the past 12 months, Blonder Tongue Laboratories has paid 12.00K in taxes.

Blonder Tongue Laboratories EV to EBITDA ratio is 21.17, with an EV/FCF ratio of 9.14.

Blonder Tongue Laboratories has $93.00K in cash and marketable securities with $8.17M in debt, giving a net cash position of -$8.08M billion.

Gross margin is 33.18%, with operating margin of -6.11%, and net profit margin of -11.18%.

The average price target for Blonder Tongue Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―